StockClub

ACUR

ACURAcura Pharmaceuticals, Inc.$ --
Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc.

ACUR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

analyticsEarnings Summary

FY2021 Q4Updated: 12/31/2021

Revenue

attach_money
0M USD
-

Operating Income

trending_up
-0M USD
-

Net Income

verified
0M USD
-

EPS

paid
0$
-

Revenue

$36,000

MISS
$7.6M
$644,000
Q1
$185,792
$613,000
Q2
$253,091
$270,000
Q3
$718,163
$36,000
Q4
$8.8M
$1.6M
Cumulative
Estimate (Forecast)Actual (Actual)
FY2021 Q4 YoY
- $-

Net Income

$29,000

BEAT
$640,942
$-259,000
Q1
$-2.4M
$-387,000
Q2
$-2.4M
$-262,000
Q3
$-438,281
$29,000
Q4
$-4.5M
$-879,000
Cumulative
Estimate (Forecast)Actual (Actual)
FY2021 Q4 YoY
- $-

Surprise History

ActualEstimate
FY2021MISS
$1.6M

Future Forecast